Bessemer Group
TAK icon

Bessemer Group’s Takeda Pharmaceutical TAK Stock Holding History

Bessemer Group’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29K Hold
1,796
– – ﹤0.01% 1870
2026
Q1 		$33K Sell
1,796
-418
-19% -$7.34K ﹤0.01% 1794
2025
Q4 		$34K Buy
2,214
+1,135
+105% +$16.2K ﹤0.01% 1741
2025
Q3 		$16K Buy
1,079
+153
+17% +$2.27K ﹤0.01% 1787
2025
Q2 		$14K Buy
926
+6
+0.7% +$89 ﹤0.01% 1693
2025
Q1 		$14K Buy
920
+753
+451% +$10.6K ﹤0.01% 1658
2024
Q4 		$2K Hold
167
– – ﹤0.01% 2271
2024
Q3 		$2K Hold
167
– – ﹤0.01% 2278
2024
Q2 		$2K Hold
167
– – ﹤0.01% 1973
2024
Q1 		$2K Hold
167
– – ﹤0.01% 1980
2023
Q4 		$2K Hold
167
– – ﹤0.01% 2058
2023
Q3 		$3K Sell
167
-1,050
-86% -$16.3K ﹤0.01% 1907
2023
Q2 		$19K Buy
1,217
+1,050
+629% +$17.2K ﹤0.01% 1533
2023
Q1 		$3K Hold
167
– – ﹤0.01% 1784
2022
Q4 		$3K Sell
167
-1,461
-90% -$20.4K ﹤0.01% 1739
2022
Q3 		$21K Buy
1,628
+1,461
+875% +$20.3K ﹤0.01% 1357
2022
Q2 		$2K Sell
167
-3,223
-95% -$46K ﹤0.01% 1769
2022
Q1 		$49K Sell
3,390
-581
-15% -$8.53K ﹤0.01% 1087
2021
Q4 		$54K Buy
3,971
+227
+6% +$3.18K ﹤0.01% 1103
2021
Q3 		$61K Sell
3,744
-196
-5% -$3.29K ﹤0.01% 1021
2021
Q2 		$66K Buy
3,940
+550
+16% +$9.36K ﹤0.01% 1023
2021
Q1 		$62K Buy
+3,390
New +$61K ﹤0.01% 972
2020
Q4 		– Sell
-372
Closed -$7K – 1547
2020
Q3 		$7K Buy
+372
New +$6.77K ﹤0.01% 1157
2019
Q4 		– Sell
-76
Closed -$1K – 1755
2019
Q3 		$1K Buy
76
+31
+69% +$536 ﹤0.01% 1682
2019
Q2 		$1K Sell
45
-352
-89% -$6.41K ﹤0.01% 1608
2019
Q1 		$8K Buy
+397
New +$7.99K ﹤0.01% 1539

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Bessemer Group's TAK Position: Q2 2026 in Review

Bessemer Group held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 1,796 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #1870.

Bessemer Group first reported a position in TAK in Q1 2019 and has held it in 26 quarters since. The position peaked at $66K in Q2 2021. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Bessemer Group held 1,796 shares of Takeda Pharmaceutical worth $29K as of Q2 2026.
  • Bessemer Group left its Takeda Pharmaceutical share count unchanged in Q2 2026.
  • Takeda Pharmaceutical made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #1870 holding.
  • Bessemer Group first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 26 quarters since.
  • Bessemer Group's Takeda Pharmaceutical position peaked at $66K in Q2 2021.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.